Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
3.740
+0.535 (16.69%)
At close: Nov 4, 2024, 4:00 PM
3.690
-0.050 (-1.34%)
After-hours: Nov 4, 2024, 4:47 PM EST
Cardiff Oncology Employees
As of December 31, 2023, Cardiff Oncology had 32 total employees, including 31 full-time and 1 part-time employees. The number of employees increased by 6 or 23.08% compared to the previous year.
Employees
32
Change (1Y)
6
Growth (1Y)
23.08%
Revenue / Employee
$20,781
Profits / Employee
-$1,277,531
Market Cap
174.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
MultiPlan | 2,800 |
Puma Biotechnology | 185 |
Repare Therapeutics | 179 |
Generation Bio Co. | 174 |
EUDA Health Holdings | 106 |
Aclaris Therapeutics | 91 |
Outlook Therapeutics | 24 |
Cardiol Therapeutics | 6 |
CRDF News
- 5 days ago - Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC - GlobeNewsWire
- 4 weeks ago - Cardiff Oncology: Paramount Data Imminent In Huge First-Line mCRC Market - Seeking Alpha
- 3 months ago - Cardiff: Second Half Of 2024 mCRC Data Is Major Inflection Point - Seeking Alpha
- 3 months ago - Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Cardiff Oncology to Present at the Jefferies Healthcare Conference - GlobeNewsWire
- 5 months ago - Cardiff Oncology's Onvansertib: A Speculative Buy With Promising Data - Seeking Alpha
- 6 months ago - Cardiff Oncology to Present at Upcoming Investor Conferences in May - GlobeNewsWire
- 6 months ago - Cardiff Oncology, Inc. (CRDF) Q1 2023 Earnings Call Transcript - Seeking Alpha